| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1668* | 2020 |
| British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus RC Fitzgerald, M Di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ... Gut 63 (1), 7-42, 2014 | 1497 | 2014 |
| The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial MM Heiss, P Murawa, P Koralewski, E Kutarska, OO Kolesnik, ... International journal of cancer 127 (9), 2209-2221, 2010 | 611 | 2010 |
| Matrix metalloproteinases SL Parsons, SA Watson, PD Brown, HM Collins, RJC Steele British Journal of Surgery 84 (2), 160-166, 1997 | 604 | 1997 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 533* | 2021 |
| Pattern and prognostic factors in patients with malignant ascites: a retrospective study AA Ayantunde, SL Parsons Annals of oncology 18 (5), 945-949, 2007 | 438 | 2007 |
| Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ... Nature genetics 46 (8), 837-843, 2014 | 374 | 2014 |
| Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ... Nature genetics 48 (10), 1131-1141, 2016 | 356 | 2016 |
| Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer BHL Tan, K Brammer, N Randhawa, NT Welch, SL Parsons, EJ James, ... European Journal of Surgical Oncology (EJSO) 41 (3), 333-338, 2015 | 300 | 2015 |
| Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer S Awad, BH Tan, H Cui, A Bhalla, KCH Fearon, SL Parsons, JA Catton, ... Clinical nutrition 31 (1), 74-77, 2012 | 289 | 2012 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 263 | 2021 |
| Gelatinase (MMP-2 and-9) expression in gastrointestinal malignancy SL Parsons, SA Watson, HM Collins, NR Griffin, PA Clarke, RJC Steele British journal of cancer 78 (11), 1495-1502, 1998 | 256 | 1998 |
| Dupuytren’s disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor JW Hutchinson, GM Tierney, SL Parsons, TRC Davis The Journal of Bone & Joint Surgery British Volume 80 (5), 907-908, 1998 | 250 | 1998 |
| Malignant ascites SL Parsons, SA Watson, RJC Steele British Journal of Surgery 83 (1), 6-14, 1996 | 213 | 1996 |
| The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic AM Frankell, SG Jammula, X Li, G Contino, S Killcoyne, S Abbas, J Perner, ... Nature genetics 51 (3), 506-516, 2019 | 189 | 2019 |
| Barrett’s dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry PV Kaye, SA Haider, M Ilyas, PD James, I Soomro, W Faisal, J Catton, ... Histopathology 54 (6), 699-712, 2009 | 164 | 2009 |
| The role of staging laparoscopy in oesophagogastric cancers GW De Graaf, AA Ayantunde, SL Parsons, JP Duffy, NT Welch European Journal of Surgical Oncology (EJSO) 33 (8), 988-992, 2007 | 153 | 2007 |
| Malignant ascites: a 2-year review from a teaching hospital SL Parsons, MW Lang, RJC Steele European Journal of Surgical Oncology (EJSO) 22 (3), 237-239, 1996 | 139 | 1996 |
| Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized … DN Lobo, RN Williams, NT Welch, MM Aloysius, QM Nunes, ... Clinical Nutrition 25 (5), 716-726, 2006 | 129 | 2006 |
| Biomarkers of response to therapy in oesophago-gastric cancer KR Fareed, P Kaye, IN Soomro, M Ilyas, S Martin, SL Parsons, ... Gut 58 (1), 127-143, 2009 | 121 | 2009 |
Dileep N LoboProfessor of Gastrointestinal Surgery, University of NottinghamVerified email at nottingham.ac.uk
